Efinaconazole
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Efinaconazole is used to treat onychomycosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 6, 2014, and the first generic was approved Dec 16, 2020. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $119 million on Efinaconazole across 101,000 claims for 35,000 beneficiaries.
Efinaconazole is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $184.60 to $184.92 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$184.60 – $184.92
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch Health US LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Azole Antifungal class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing EFINACONAZOLE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
JUBLIA 10% TOPICAL SOLUTION | $184.9189 per ML | — |
JUBLIA 10% TOPICAL SOLUTION | $184.6035 per ML | — |
Frequently Asked Questions
What is Efinaconazole used to treat?
Efinaconazole is used to treat onychomycosis, per the National Library of Medicine's MED-RT classification.
When did Efinaconazole become available as a generic?
FDA approved the first generic Efinaconazole (ANDA) on Dec 16, 2020. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Efinaconazole?
In 2024, Medicare Part D spent $119 million on Efinaconazole across 101,000 claims for 35,000 beneficiaries.
How many Efinaconazole products are on the market?
The Efinaconazole drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Efinaconazole?
NADAC reference prices for Efinaconazole range from $184.6035 to $184.9189 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Efinaconazole?
1 manufacturer lists Efinaconazole in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (2).